Cours Evogene Ltd TEL AVIV STOCK EXCHANGE
Actions
IL0011050551
Recherche biotechnologique et médicale
CA 2024 * | 17 M 6,29 Md 15,45 M | CA 2025 * | 31,5 M 11,65 Md 28,63 M | Capitalisation | 36,46 M 13,48 Md 33,14 M |
---|---|---|---|---|---|
Résultat net 2024 * | -20 M -7,4 Md -18,18 M | Résultat net 2025 * | -17 M -6,29 Md -15,45 M | VE / CA 2024 * | 2,14 x |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | 1,16 x |
PER 2024 * |
-
| PER 2025 * |
-
| Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 98,34% |
Dernier transcript sur Evogene Ltd
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ofer Haviv
CEO | Chief Executive Officer | 58 | 01/01/02 |
Yaron Eldad
DFI | Director of Finance/CFO | 57 | 01/04/22 |
Mark Kapel
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/01/05 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Dan Falk
BRD | Director/Board Member | 79 | 17/11/21 |
Sarit Firon
CHM | Chairman | 58 | 11/08/16 |
Leon Recanati
BRD | Director/Board Member | 76 | 01/05/05 |
Varia. 1 janv. | Capi. | |
---|---|---|
+21,74% | 46,81 Md | |
-0,97% | 41,37 Md | |
+47,07% | 41,29 Md | |
-3,52% | 28,87 Md | |
+11,12% | 26,06 Md | |
-19,37% | 19,13 Md | |
+31,18% | 12,39 Md | |
-0,04% | 12,08 Md | |
+0,39% | 11,96 Md |